| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/18/2010 | US20100040550 Radiolabelling methods |
| 02/18/2010 | US20100040539 Vector System |
| 02/18/2010 | US20100040537 antibodies that are wild-type, chimeric, CDR grafted and humanized; disease or disorder in which prostaglandin E2 activity is detrimental, such as cancer, atuoimmune diseases, inflammatory diseases |
| 02/18/2010 | CA2736580A1 An expression vector and a method thereof |
| 02/18/2010 | CA2734335A1 Human antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof |
| 02/18/2010 | CA2734179A1 Micro-rna-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma |
| 02/18/2010 | CA2734131A1 Temperature controlled nucleic-acid detection method suitable for practice in a closed-system |
| 02/18/2010 | CA2734128A1 Methods for the production of ips cells |
| 02/18/2010 | CA2733898A1 Polyvalent vaccine |
| 02/18/2010 | CA2733775A1 Agent for promoting neuronal differentiation and method therefor |
| 02/18/2010 | CA2733742A1 Variant domain antibodies |
| 02/18/2010 | CA2733567A1 Improved vectors and yeast strains for protein production: ca2+ atpase overexpression |
| 02/18/2010 | CA2733545A1 Modified biotin-binding protein |
| 02/18/2010 | CA2732800A1 Transgenic plants |
| 02/18/2010 | CA2731975A1 Plants with altered root architecture, related constructs and methods involving genes encoding protein phophatase 2c (pp2c) polypeptides and homologs thereof |
| 02/17/2010 | EP2154535A1 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2010 | EP2154252A1 Methods for producing secreted proteins |
| 02/17/2010 | EP2154251A1 Expression system of recombinant proteins with enhanced yield and immunogenicity |
| 02/17/2010 | EP2154250A1 Xenobiotic related induction of gene expression of cytochrome CYP3A4 |
| 02/17/2010 | EP2154249A1 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 02/17/2010 | EP2154248A1 Compounds and methods for diagnosis of tuberculosis |
| 02/17/2010 | EP2154246A1 Viral vector and use thereof |
| 02/17/2010 | EP2154245A2 Composition and method for diagnosing kidney cancer and for predicting prognosis for kidney cancer patient |
| 02/17/2010 | EP2154244A1 Cell culture method using amino acid-enriched medium |
| 02/17/2010 | EP2154242A1 Method of inducing differentiation into myocardial cells using g-csf |
| 02/17/2010 | EP2154160A1 Hydroxyalkyl starch derivatives |
| 02/17/2010 | EP2154159A1 Activated protease indicator |
| 02/17/2010 | EP2154156A2 Analysis of agonist-activity and antagonist-activity to cytokinin receptor |
| 02/17/2010 | EP2154155A2 Analysis of agonist-activity and antagonist-activity to cytokinin receptor |
| 02/17/2010 | EP2154154A1 G-protein-conjugated receptor having altered ligand affinity, and use thereof |
| 02/17/2010 | EP2154153A1 Mutant alpha-synuclein, and methods using same |
| 02/17/2010 | EP2154150A1 Genes for biosynthesis of tetracycline compounds and uses thereof |
| 02/17/2010 | EP2154149A1 A truncated l1 protein of human papillomavirus 6 |
| 02/17/2010 | EP2154148A1 A truncated l1 protein of human papillomavirus 11 |
| 02/17/2010 | EP2154147A1 A truncated l1 protein of human papillomavirus 16 |
| 02/17/2010 | EP2153846A1 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immonostimulatory molecule |
| 02/17/2010 | EP2153843A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/17/2010 | EP2152892A2 Method for introducing nucleic acids into fungal cells |
| 02/17/2010 | EP2152891A2 Genes and uses for plant enhancement |
| 02/17/2010 | EP2152890A1 Multicistronic vectors and methods for their design |
| 02/17/2010 | EP2152888A2 Enhancement of seed oil / amino acid content by combinations of pyruvate kinase subunits |
| 02/17/2010 | EP2152887A1 Yield enhancement in plants by modulation of garp transcripton factor zmrr10_p |
| 02/17/2010 | EP2152886A2 Transgenic plants with increased stress tolerance and yield |
| 02/17/2010 | EP2152885A2 Polynucleotide markers |
| 02/17/2010 | EP2152884A1 Methods and means for producing glycoproteins with altered glycosylation pattern in higher plants |
| 02/17/2010 | EP2152882A2 Cells expressing chimeric proteins and assays using such cells |
| 02/17/2010 | EP2152881A2 Rumc peptides with antimicrobial activity |
| 02/17/2010 | EP2152879A2 Rna antagonist compounds for the modulation of beta-catenin |
| 02/17/2010 | EP2152874A2 Rna interference suppression of neurodegenerative diseases and methods of use thereof |
| 02/17/2010 | EP2152873A2 Gene expression regulation technology and noncoding rnas for diagnosis and therapy |
| 02/17/2010 | EP2152872A2 Method for manufacturing a recombinant polyclonal protein |
| 02/17/2010 | EP2152869A1 Liposome drug carriers with ph-sensitivity |
| 02/17/2010 | EP2152863A1 Human parainfluenza viruses having separated p and c genes |
| 02/17/2010 | EP2152861A2 Inducible mutagenesis of target genes |
| 02/17/2010 | EP2152850A2 Device for the lysis of microorganisms present in an environmental or clinical sample and the extraction of nucleic acids from said microorganisms for analysis |
| 02/17/2010 | EP2152753A1 Antibodies against ramp3 |
| 02/17/2010 | EP2152748A1 Anti-notch1 nrr antibodies and methods using same |
| 02/17/2010 | EP2152746A1 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 02/17/2010 | EP2152739A2 Mutants of interleukin-1 receptor antagonist and uses thereof |
| 02/17/2010 | EP2152736A1 Complement factor h-derived short consensus repeat-antibody constructs |
| 02/17/2010 | EP2152734A1 Yield enhancement in plants by modulation of maize mads box transcription factor zmm28 |
| 02/17/2010 | EP2152733A2 Yield enhancement in plants by modulation of maize alfins |
| 02/17/2010 | EP2152732A1 A modified secretion system to increase expression of polypeptides in bacteria |
| 02/17/2010 | EP2152728A2 Mammalian expression vector with a highly efficient secretory signal sequence |
| 02/17/2010 | EP2152722A2 Compositions comprising mir34 therapeutic agents for treating cancer |
| 02/17/2010 | EP2152317A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 02/17/2010 | EP2152316A2 Therapeutic delivery of inhibitory nucleic acid molecules to the respiratory system |
| 02/17/2010 | EP2152276A1 Screening assay to identify correctors of protein trafficking defects |
| 02/17/2010 | EP2152275A1 Methods of identifying genes involved in memory formation using small interfering rna(sirna) |
| 02/17/2010 | EP1945769B1 Glutathione-s-transferase gene from prosopis juliflora confers abiotic stress tolerance in plants |
| 02/17/2010 | EP1799748B1 Biodegradable cationic polymers |
| 02/17/2010 | EP1715037B1 Method of amplifying nucleic acid |
| 02/17/2010 | EP1674578B1 Process for producing scyllo-inositol |
| 02/17/2010 | EP1644504B1 Factor vii or viia gla domain variants |
| 02/17/2010 | EP1627049B1 Novel trichoderma genes |
| 02/17/2010 | EP1578919B1 Endogenous retrovirus up-regulated in prostate cancer |
| 02/17/2010 | EP1565053B1 Compositions and methods for altering tocotrienol content |
| 02/17/2010 | EP1537227B1 Method for efficient rna interference in mammalian cells |
| 02/17/2010 | EP1516186B1 A method for the detection of apoptosis |
| 02/17/2010 | EP1492410B1 Triglyceride fat |
| 02/17/2010 | EP1490013B1 Methods for enhancing oligonucleotide-mediated nucleic acid sequence alteration using compositions comprising hydroxyurea |
| 02/17/2010 | EP1443111B1 Desmin gene having novel point mutation causative of dilated cardiomyopathy |
| 02/17/2010 | EP1427852B1 Single nucleotide amplification and detection by polymerase |
| 02/17/2010 | EP1421213B1 Labeled nucleoside polyphosphates |
| 02/17/2010 | EP1404816B1 Human hepatoma cell lines, methods for obtaining same and uses thereof |
| 02/17/2010 | EP1383732B1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules |
| 02/17/2010 | EP1263954B1 Low density liprotein binding proteins and their use in diagnosing and treating atherosclerosis |
| 02/17/2010 | EP1240186B1 Improvements in or relating to immune responses to hiv |
| 02/17/2010 | EP1133560B1 Human parathyroid hormone modifications, preparation and use |
| 02/17/2010 | EP1117814B1 Isoforms of starch branching enzyme ii (sbe-iia and sbe-iib) from wheat |
| 02/17/2010 | EP1117783B1 Gene expressed in prostate cancer |
| 02/17/2010 | EP1073722B1 Pyruvate carboxylase overexpression for enhanced production of oxaloacetate-derived biochemicals in microbial cells |
| 02/17/2010 | EP1071700B1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
| 02/17/2010 | CN101652481A selective ablation of diploid embryos |
| 02/17/2010 | CN101652480A Transgenic plant with increased stress tolerance and yield |
| 02/17/2010 | CN101652479A Methods of reducing or eliminating expression of genes in filamentous fungal strains by transitive RNA interference |
| 02/17/2010 | CN101652478A Probe for detecting polymorphism in gene involved in immunity, and use thereof |
| 02/17/2010 | CN101652477A dna encoding xylitol dehydrogenase |
| 02/17/2010 | CN101652476A Anti-FGF23 antibody and pharmaceutical composition comprising the same |
| 02/17/2010 | CN101652475A Transgene expression in avians |